Conversely, the p53 R175H mutant, which has oncogenic gain-of-function properties, suppresses ferroptosis by abolishing BTB and CNC homology 1 (BACH1)-mediated downregulation of SLC7A11 expression, leading to enhanced tumor growth (Su et al., 2023). This evidence concerns the gene TP53 and neoplasm.